Figure 4From: Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical viewProgression-free survival and overall survival according to KRAS mutation and metastatic site in patients with metastatic disease limited to one distant organ. A, C – progression-free survival; B, D – overall survival.Back to article page